Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on hemodialysis undergoing autologous stem cell transplantation: Clinical response after plasma exchange-Reference-Cited by-同舟云学术

Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on hemodialysis undergoing autologous stem cell transplantation: Clinical response after plasma exchange

Published:2009-09 Issue:4 Volume:21 Page:240-243
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

Focosi Daniele,Pelosini Matteo,Palla Piero,Galimberti Sara,Caracciolo Francesco,Benedetti Edoardo,Papineschi Federico,Petrini Mario

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference45 articles.

1. Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure;Tosi;Leukemia,2000

2. Glomerular filtration rate prior to high-dose melphalan 200 mg/m2 as a surrogate marker of outcome in patients with myeloma;Sirohi;Br J Cancer,2001

3. Encephalopathy complicating high-dose melphalan;Schuh;Bone Marrow Transplant,1999

4. Results of autologous stem cell transplant in multiple myeloma patients with renal failure;Badros;Br J Haematol,2001

5. Neurological complications after autologous stem cell transplantation;Guerrero;Eur Neurol,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Encephalopathy following melphalan administration;Journal of Chemotherapy;2016-04-22

2. Brain Teaser: Encephalopathy After Stem Cell Transplantation;The American Journal of Medicine;2014-04

3. Encephalopathy: an unusual neurologic complication of autologous hematopoietic stem cell transplant in patients with multiple myeloma with renal failure;Leukemia & Lymphoma;2012-11-06

4. Melphalan Culprit or Confounder in Acute Encephalopathy during Autologous Hematopoietic Stem Cell Transplantation?;Case Reports in Transplantation;2012